Tobias Ruck

Department of Neurology, University of Münster

Affiliated withUniversity of Münster University of Muenster University of Muenster

Research Area

Biography

Tobias Ruck has not added Biography.
If you are Tobias Ruck and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 3	Year
Publication title Cited by 110	2014
Publication title Cited by 9	2019
Publication title	2023

Other Publications

Article	Year
FOXP3+ T regulatory cells in idiopathic inflammatory myopathies. Journal of neuroimmunology\| PubMed ID: 20537411	2010
Active immunization with proteolipid protein (190-209) induces ascending paralysing experimental autoimmune encephalomyelitis in C3H/HeJ mice. Journal of immunological methods\| PubMed ID: 21199659	2011
Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS. Nature medicine\| PubMed ID: 23933981	2013
DTI detects water diffusion abnormalities in the thalamus that correlate with an extremity pain episode in a patient with multiple sclerosis. NeuroImage. Clinical\| PubMed ID: 24179780	2013
CD4+NKG2D+ T cells exhibit enhanced migratory and encephalitogenic properties in neuroinflammation. PloS one\| PubMed ID: 24282598	2013
TREK-King the Blood-Brain-Barrier. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology\| PubMed ID: 24557892	2014
Human CD4+ HLA-G+ regulatory T cells are potent suppressors of graft-versus-host disease in vivo. FASEB journal : official publication of the Federation of American Societies for Experimental Biology\| PubMed ID: 24744146	2014
Phospholipase D1 mediates lymphocyte adhesion and migration in experimental autoimmune encephalomyelitis. European journal of immunology\| PubMed ID: 24811005	2014
Effects of glatiramer acetate in a spontaneous model of autoimmune neuroinflammation. The American journal of pathology\| PubMed ID: 24819960	2014
Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond. International journal of molecular sciences\| PubMed ID: 26204829	2015
Murine K2P5.1 Deficiency Has No Impact on Autoimmune Neuroinflammation due to Compensatory K2P3.1- and KV1.3-Dependent Mechanisms. International journal of molecular sciences\| PubMed ID: 26213925	2015
The NKG2D-IL-15 signaling pathway contributes to T-cell mediated pathology in inflammatory myopathies. Oncotarget\| PubMed ID: 26646698	2015
CD4(+)HLA-G(+) regulatory T cells: Molecular signature and pathophysiological relevance. Human immunology\| PubMed ID: 26826445	2016
ALAIN01--Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potential. BMC neurology\| PubMed ID: 26966029	2016
Failed, interrupted and inconclusive trials on relapsing multiple sclerosis treatment: update 2010-2015. Expert review of neurotherapeutics\| PubMed ID: 27058174	2016
The potassium channels TASK2 and TREK1 regulate functional differentiation of murine skeletal muscle cells. American journal of physiology. Cell physiology\| PubMed ID: 27488672	2016
Animal models in idiopathic inflammatory myopathies: How to overcome a translational roadblock? Autoimmunity reviews\| PubMed ID: 28286105	2017
An Enigmatic Case of Acute Mercury Poisoning: Clinical, Immunological Findings and Platelet Function. Frontiers in neurology\| PubMed ID: 29033890	2017
Skeletal muscle cells actively shape (auto)immune responses. Autoimmunity reviews\| PubMed ID: 29526638	2018
Vitiligo after alemtuzumab treatment: Secondary autoimmunity is not all about B cells. Neurology\| PubMed ID: 30404783	2018
Efficacy and safety of alemtuzumab versus fingolimod in RRMS after natalizumab cessation. Journal of neurology\| PubMed ID: 30446966	2019
Teriflunomide treatment is associated with optic nerve recovery in early multiple sclerosis. Therapeutic advances in neurological disorders\| PubMed ID: 33747129	2021
K18.1 translates T cell receptor signals into thymic regulatory T cell development. Cell research\| PubMed ID: 34702947	2022
Mini-Review: Two Brothers in Crime - The Interplay of TRESK and TREK in Human Diseases. Neuroscience letters\| PubMed ID: 34852287	2022
Eculizumab versus rituximab in generalised myasthenia gravis. Journal of neurology, neurosurgery, and psychiatry\| PubMed ID: 35246490	2022
Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients. Journal of neuroinflammation\| PubMed ID: 35413850	2022
Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis. Acta neuropathologica\| PubMed ID: 35612662	2022
Deficiency of the Two-Pore Potassium Channel KCNK9 Impairs Intestinal Epithelial Cell Survival and Aggravates Dextran Sodium Sulfate-Induced Colitis. Cellular and molecular gastroenterology and hepatology\| PubMed ID: 35973573	2022
Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis. Neurological research and practice\| PubMed ID: 36336685	2022
Myositis in Germany: epidemiological insights over 15 years from 2005 to 2019. Neurological research and practice\| PubMed ID: 36581896	2022
Driving time-based identification of gaps in specialised care coverage: An example of neuroinflammatory diseases in Germany. Digital health\| PubMed ID: 36762020	2023
Introducing electronic monitoring of disease activity in patients with chronic inflammatory demyelinating polyneuropathy (EMDA CIDP): trial protocol of a proof of concept study. Neurological research and practice\| PubMed ID: 37612774	2023
Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis. Acta neuropathologica\| PubMed ID: 37773216	2023